Detection of Class I Integrons in Staphyloacoccus aurous Isolated From Clinical Samples

Emad Yahaghi1, Abbas Ali Imani Fooladi2, Mohsen Amin3

  • 1Department of Microbiology, Science and Research Branch, Islamic Azad University, Damghan, IR Iran.

Abstract

Insights

Class 1 integrons were found in a limited frequency (1%) of Staphylococcus aureus strains from clinical samples in Tehran. This study highlights the presence of these resistance genes in Iranian S. aureus isolates.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Staphylococcus aureus is a significant global pathogen responsible for various diseases and mortality.
  • Antibiotic resistance in S. aureus is a growing concern, exacerbated by the inappropriate use of antibiotics and the spread of resistance genes.
  • Integrons, such as class 1 integrons, are mobile genetic elements that contribute to antibiotic resistance by carrying gene cassettes.

Purpose of the Study:

  • To investigate the prevalence of class 1 integrons in Staphylococcus aureus strains from clinical samples in Iran for the first time.
  • To identify potential sources and demographic factors associated with S. aureus carrying class 1 integrons.

Main Methods:

  • A descriptive study was conducted on 200 S. aureus strains isolated from patients at Baqiyatallah Hospital, Tehran, in 2013.
  • Strains were confirmed using biochemical and serological tests.
  • Polymerase chain reaction (PCR) was employed to detect the presence of the class 1 integron gene.

Main Results:

  • Class 1 integrons were detected in 1% (two isolates) of the 200 S. aureus strains analyzed.
  • The majority of isolates were from male patients, predominantly in the 51-60 age group.
  • Wound samples yielded the highest number of strains, with frequent isolation from emergency and intensive care units.

Conclusions:

  • Class 1 integrons exhibit a limited frequency in Staphylococcus aureus strains isolated from clinical samples in Tehran.
  • These findings provide initial data on the prevalence of class 1 integrons in Iranian S. aureus, contributing to understanding antimicrobial resistance patterns.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
60
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
100
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
54
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
155